Eterna Therapeutics
ERNA
#9824
Rank
โ‚น0.51 B
Marketcap
โ‚น94.50
Share price
4.67%
Change (1 day)
3.11%
Change (1 year)

Revenue for Eterna Therapeutics (ERNA)

Revenue in 2024 (TTM): โ‚น13.49 Million

According to Eterna Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น13.66 Million. In 2023 the company made a revenue of โ‚น5.66 Million an increase over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Eterna Therapeutics from 2020 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น13.49 M138.38%
2023 โ‚น5.66 M
2022 N/A
2021 N/A
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น1.265 T 9,257,307.41%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.11 B 747.53%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.514 T 33,028,997.80%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น97.79 B 715,369.14%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.44 B 10,457.32%๐Ÿ‡ฆ๐Ÿ‡บ Australia
โ‚น1.374 T 10,055,455.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel